Edition:
United Kingdom

DaVita Inc (DVA.N)

DVA.N on New York Stock Exchange

56.05USD
19 Jul 2019
Change (% chg)

$-0.69 (-1.22%)
Prev Close
$56.74
Open
$56.70
Day's High
$56.75
Day's Low
$55.98
Volume
242,458
Avg. Vol
393,979
52-wk High
$79.02
52-wk Low
$43.40

About

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administra... (more)

Overall

Beta: 1.59
Market Cap(Mil.): $9,326.72
Shares Outstanding(Mil.): 166.40
Dividend: --
Yield (%): --

Financials

  DVA.N Industry Sector
P/E (TTM): 17.20 22.54 34.52
EPS (TTM): 3.26 -- --
ROI: 5.17 8.79 12.69
ROE: 13.03 -1.05 17.17

UnitedHealth gets FTC approval for DaVita unit purchase

UnitedHealth Group Inc won anti-trust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday.

20 Jun 2019

UPDATE 3-UnitedHealth gets FTC approval for DaVita unit purchase

June 19 UnitedHealth Group Inc won anti-trust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday.

19 Jun 2019

U.S. FTC approves UnitedHealth's proposed purchase of DaVita unit

WASHINGTON, June 19 UnitedHealth Group Inc won antitrust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday. (Reporting by Diane Bartz Editing by Leslie Adler)

19 Jun 2019

Earnings vs. Estimates